NAS:MASI (USA) Also trade in: Germany UK

Masimo Corp

$ 138.5 -2.27 (-1.61%)
Volume: 524,561 Avg Vol (1m): 490,412
Market Cap $: 7.39 Bil Enterprise Value $: 6.80 Bil
P/E (TTM): 39.47 P/B: 7.84
Earnings Power Value 35.24
Net Current Asset Value 11.9
Tangible Book 16.81
Projected FCF 47.03
Median P/S Value 65.37
Graham Number 36.44
Peter Lynch Value 80.13
DCF (FCF Based) 36.83
DCF (Earnings Based) 91.09
YTD (-%)

Financial Strength : 10/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt ranked higher than
89.27% of 205 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
MASI: No Debt
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.49, Med: 368.39, Max: 10000
Current: 10000
0.49
10000
Equity-to-Asset 0.85
Equity-to-Asset ranked higher than
60.20% of 196 companies
in the Medical Instruments & Supplies industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
MASI: 0.85
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -1.01, Med: 0.74, Max: 0.85
Current: 0.85
-1.01
0.85
Interest Coverage No Debt
Interest Coverage ranked higher than
91.24% of 137 companies
in the Medical Instruments & Supplies industry.
Industry Max: 21607070, Med: 63.92, Min: 0.47
MASI: No Debt
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1096.35, Med: 10000, Max: 10000
Current: 10000
1096.35
10000
Piotroski F-Score 8
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 29.08
DISTRESS
GREY
SAFE
Beneish M-Score -2.46
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 46.66%
WACC 10.32%

Profitability & Growth : 9/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 24.01
Operating Margin ranked higher than
87.56% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
MASI: 24.01
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 15.88, Med: 19.17, Max: 24.29
Current: 24.01
15.88
24.29
Net Margin % 22.49
Net Margin ranked higher than
78.61% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
MASI: 22.49
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 10.67, Med: 14.88, Max: 43.64
Current: 22.49
10.67
43.64
ROE % 22.02
ROE ranked higher than
84.85% of 198 companies
in the Medical Instruments & Supplies industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
MASI: 22.02
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 19.43, Med: 22.9, Max: 74.46
Current: 22.02
19.43
74.46
ROA % 18.31
ROA ranked higher than
88.35% of 206 companies
in the Medical Instruments & Supplies industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
MASI: 18.31
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 14.28, Med: 16.6, Max: 43.75
Current: 18.31
14.28
43.75
ROC (Joel Greenblatt) % 84.20
ROC (Joel Greenblatt) ranked higher than
89.22% of 204 companies
in the Medical Instruments & Supplies industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
MASI: 84.2
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 68.84, Med: 109.38, Max: 261.45
Current: 84.2
68.84
261.45
3-Year Total Revenue Growth Rate 10.90
3-Year Revenue Growth Rate ranked higher than
52.94% of 170 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
MASI: 9.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -19.3, Med: 12.15, Max: 30.3
Current: 9.3
-19.3
30.3
3-Year Total EBITDA Growth Rate 25.40
3-Year EBITDA Growth Rate ranked higher than
54.84% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 426.6, Med: 10, Min: -759
MASI: 23.7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 6.45, Max: 420.3
Current: 23.7
0
420.3
3-Year EPS w/o NRI Growth Rate 30.60
3-Year EPS w/o NRI Growth Rate ranked higher than
55.48% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 253, Med: 12.9, Min: -782.7
MASI: 30.6
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 7.75, Max: 79
Current: 30.6
0
79

» MASI's 30-Y Financials

Financials (Next Earnings Date: 2019-08-01)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:MASI

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 339112    SIC : 3841
Compare NYSE:HRC TSE:7747 OCSE:DEMANT NZSE:FPH XTER:AFX NYSE:WST NAS:ICUI NYSE:HAE OSTO:EKTA B NAS:NVCR MIL:AMP OSTO:GETI B SZSE:002294 LSE:CTEC NAS:MMSI NYSE:CMD NYSE:STE NYSE:GKOS ASX:ANN NAS:XRAY
Traded in other countries 3M4.Germany 0JZ2.UK
Address 52 Discovery, Irvine, CA, USA, 92618
Masimo is an Irvine, California-based medical device business focusing on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue on a global basis, with the United States representing the largest market (68% of 2017 sales), followed by Europe, the Middle East and Africa (19%), Asia and Australia (10%), and North and South America excluding the U.S. (3%).

Ratios

Current vs industry vs history
PE Ratio (TTM) 39.47
PE Ratio ranked higher than
74.40% of 125 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1012.86, Med: 31.7, Min: 0.65
MASI: 39.47
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 10.97, Med: 25.35, Max: 58.88
Current: 39.47
10.97
58.88
Forward PE Ratio 45.05
Forward P/E ranked lower than
87.50% of 40 companies
in the Medical Instruments & Supplies industry.
Industry Max: 80, Med: 26.32, Min: 12.3
MASI: 45.05
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 39.47
PE without NRI ranked higher than
76.42% of 123 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1012.86, Med: 9999, Min: 0.65
MASI: 39.47
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 10.97, Med: 25.35, Max: 58.88
Current: 39.47
10.97
58.88
Price-to-Owner-Earnings 56.15
Price-to-Owner-Earnings ranked lower than
100.00% of 83 companies
in the Medical Instruments & Supplies industry.
Industry Max: 631.1, Med: 30.92, Min: 1.32
MASI: 56.15
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 8.94, Med: 30.94, Max: 215.95
Current: 56.15
8.94
215.95
PB Ratio 7.84
PB Ratio ranked lower than
100.00% of 193 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
MASI: 7.84
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 3.41, Med: 6.17, Max: 12.3
Current: 7.84
3.41
12.3
PS Ratio 8.82
PS Ratio ranked lower than
100.00% of 192 companies
in the Medical Instruments & Supplies industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
MASI: 8.82
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 2.1, Med: 4.16, Max: 8.96
Current: 8.82
2.1
8.96
Price-to-Free-Cash-Flow 41.29
Price-to-Free-Cash-Flow ranked lower than
100.00% of 74 companies
in the Medical Instruments & Supplies industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
MASI: 41.29
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 8.39, Med: 29.76, Max: 2401.82
Current: 41.29
8.39
2401.82
Price-to-Operating-Cash-Flow 36.71
Price-to-Operating-Cash-Flow ranked lower than
100.00% of 94 companies
in the Medical Instruments & Supplies industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
MASI: 36.71
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 7.89, Med: 22.14, Max: 91.96
Current: 36.71
7.89
91.96
EV-to-EBIT 32.26
EV-to-EBIT ranked lower than
63.64% of 121 companies
in the Medical Instruments & Supplies industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
MASI: 32.26
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 11.2, Med: 19.1, Max: 35.7
Current: 32.26
11.2
35.7
EV-to-EBITDA 29.32
EV-to-EBITDA ranked lower than
73.19% of 138 companies
in the Medical Instruments & Supplies industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
MASI: 29.32
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 10.3, Med: 17.3, Max: 33
Current: 29.32
10.3
33
EV-to-Revenue 7.75
EV-to-Revenue ranked lower than
100.00% of 199 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
MASI: 7.75
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 2, Med: 3.95, Max: 8.4
Current: 7.75
2
8.4
PEG Ratio 1.89
PEG Ratio ranked higher than
73.91% of 69 companies
in the Medical Instruments & Supplies industry.
Industry Max: 112.54, Med: 2.7, Min: 0.05
MASI: 1.89
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.66, Med: 2.68, Max: 9.24
Current: 1.89
0.66
9.24
Shiller PE Ratio 64.28
Shiller PE Ratio ranked lower than
53.70% of 54 companies
in the Medical Instruments & Supplies industry.
Industry Max: 600, Med: 50.97, Min: 0.42
MASI: 64.28
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 20.24, Med: 48.35, Max: 65.47
Current: 64.28
20.24
65.47
Current Ratio 7.02
Current Ratio ranked lower than
56.50% of 200 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
MASI: 7.02
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.25, Med: 3.01, Max: 7.02
Current: 7.02
1.25
7.02
Quick Ratio 6.25
Quick Ratio ranked lower than
55.22% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
MASI: 6.25
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.99, Med: 2.5, Max: 6.25
Current: 6.25
0.99
6.25
Days Inventory 114.63
Days Inventory ranked lower than
62.94% of 197 companies
in the Medical Instruments & Supplies industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
MASI: 114.63
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 100.9, Med: 110.68, Max: 119.79
Current: 114.63
100.9
119.79
Days Sales Outstanding 49.04
Days Sales Outstanding ranked higher than
52.73% of 165 companies
in the Medical Instruments & Supplies industry.
Industry Max: 655.77, Med: 61.97, Min: 1
MASI: 49.04
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 40.67, Med: 47.15, Max: 54.75
Current: 49.04
40.67
54.75
Days Payable 40.91
Days Payable ranked lower than
100.00% of 151 companies
in the Medical Instruments & Supplies industry.
Industry Max: 713.41, Med: 54.66, Min: 2
MASI: 40.91
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 40.91, Med: 56.67, Max: 70.9
Current: 40.91
40.91
70.9

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.70
3-Year Share Buyback Rate ranked higher than
82.52% of 143 companies
in the Medical Instruments & Supplies industry.
Industry Max: 9.1, Med: -5, Min: -273.3
MASI: -3.7
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -79.8, Med: -1.65, Max: 4.3
Current: -3.7
-79.8
4.3

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 8.24
Price-to-Tangible-Book ranked lower than
100.00% of 167 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3100, Med: 4.77, Min: 0.22
MASI: 8.24
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 4.11, Med: 6.62, Max: 14.94
Current: 8.24
4.11
14.94
Price-to-Projected-FCF 2.94
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
81.33% of 75 companies
in the Medical Instruments & Supplies industry.
Industry Max: 161.65, Med: 2.41, Min: 0.16
MASI: 2.94
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.34, Med: 2.32, Max: 3.93
Current: 2.94
1.34
3.93
Price-to-DCF (Earnings Based) 1.52
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked lower than
100.00% of 23 companies
in the Medical Instruments & Supplies industry.
Industry Max: 94.53, Med: 2.2, Min: 1.04
MASI: 1.52
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 1.26, Med: 1.43, Max: 1.6
Current: 1.52
1.26
1.6
Price-to-Median-PS-Value 2.12
Price-to-Median-PS-Value ranked lower than
100.00% of 160 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
MASI: 2.12
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.49, Med: 1, Max: 2.14
Current: 2.12
0.49
2.14
Price-to-Peter-Lynch-Fair-Value 1.73
Price-to-Peter-Lynch-Fair-Value ranked higher than
64.44% of 45 companies
in the Medical Instruments & Supplies industry.
Industry Max: 111.95, Med: 2.46, Min: 0.26
MASI: 1.73
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.67, Med: 1.92, Max: 5.6
Current: 1.73
0.67
5.6
Price-to-Graham-Number 3.80
Price-to-Graham-Number ranked lower than
91.49% of 94 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.19, Med: 2.77, Min: 0.13
MASI: 3.8
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 1.8, Med: 2.9, Max: 6.58
Current: 3.8
1.8
6.58
Earnings Yield (Joel Greenblatt) % 3.09
Earnings Yield (Greenblatt) ranked higher than
63.29% of 207 companies
in the Medical Instruments & Supplies industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
MASI: 3.09
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 2.8, Med: 5.2, Max: 9
Current: 3.09
2.8
9
Forward Rate of Return (Yacktman) % 21.83
Forward Rate of Return ranked higher than
91.09% of 101 companies
in the Medical Instruments & Supplies industry.
Industry Max: 28.23, Med: 8.66, Min: -123.3
MASI: 21.83
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -30.4, Med: 8.7, Max: 22.5
Current: 21.83
-30.4
22.5

More Statistics

Revenue (TTM) (Mil) $ 877
EPS (TTM) $ 3.51
Beta 1.32
Volatility % 29.01
52-Week Range $ 95.85 - 147.91
Shares Outstanding (Mil) 53.09

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 8
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y